<SEC-DOCUMENT>0001171843-19-002720-index.html : 20190429 <SEC-HEADER>0001171843-19-002720.hdr.sgml : 20190429 <ACCEPTANCE-DATETIME>20190429164616 ACCESSION NUMBER: 0001171843-19-002720 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20190429 DATE AS OF CHANGE: 20190429 EFFECTIVENESS DATE: 20190429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-231108 FILM NUMBER: 19776601 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>s8_042919.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: s8_042919.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>exh_51.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: exh_51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>exh_231.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: exh_231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>exh_991.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 4 - file: exh_991.htm
</DOCUMENT> </SEC-DOCUMENT>